Imagine fighting dengue fever, only to have your insurance claim rejected over a technicality. That's the reality one patient faced when his insurer denied coverage because his platelet count never fell below 70,000—a decision that has ignited discussions about medical policy fairness.

  • Patient diagnosed with dengue fever
  • Insurance claim rejected due to platelet count not dropping below 70,000
  • Case reported by Moneycontrol.com through Google News aggregation

The Medical Threshold Question

Insurance companies often set specific medical parameters for claim approvals, but this case shows how rigid interpretations can create barriers for legitimate patients. The platelet count threshold of 70,000 became the determining factor, leaving the patient to bear the financial burden of treatment.

Broader Implications for Policyholders

This situation raises important questions about how insurance policies are written and enforced. When medical guidelines become absolute barriers rather than contextual indicators, patients may find themselves caught between clinical reality and contractual fine print.

Transparency and Communication Gaps

The case underscores the need for clearer communication between insurers and policyholders about coverage criteria. Many patients only discover these specific requirements when facing a health crisis, leaving little room for preparation or appeal.